The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
BioPharma Service-Global Market Insights and Sales Trends 2024
Synopsis
The global BioPharma Service market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of BioPharma Service in various end use industries. The expanding demands from the Analytical Testing, Drug Development Service, Drug Packaging and Delivery and Others, are propelling BioPharma Service market. Raw Material, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the In-Process and Product segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for BioPharma Service, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global BioPharma Service market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global BioPharma Service market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, BioPharma Service sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of BioPharma Service covered in this report include Eurofins, Pace Analytical Services, Catalent, Envigo, PPD, Element, ALS, Intertek and SGS, etc.
The global BioPharma Service market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins
Pace Analytical Services
Catalent
Envigo
PPD
Element
ALS
Intertek
SGS
Boston Analytical
EAG
Maxxam
ARL Bio Pharma
West Pharmaceutical
BioScreen
Microbac
RD Laboratories
Analytical Lab Group
Piramal Pharma Solutions
Global BioPharma Service market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BioPharma Service market, Segment by Type:
Raw Material
In-Process and Product
Finished Pharmaceutical
Others
Global BioPharma Service market, by Application
Analytical Testing
Drug Development Service
Drug Packaging and Delivery
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of BioPharma Service companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global BioPharma Service market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of BioPharma Service in various end use industries. The expanding demands from the Analytical Testing, Drug Development Service, Drug Packaging and Delivery and Others, are propelling BioPharma Service market. Raw Material, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the In-Process and Product segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for BioPharma Service, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global BioPharma Service market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global BioPharma Service market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, BioPharma Service sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of BioPharma Service covered in this report include Eurofins, Pace Analytical Services, Catalent, Envigo, PPD, Element, ALS, Intertek and SGS, etc.
The global BioPharma Service market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins
Pace Analytical Services
Catalent
Envigo
PPD
Element
ALS
Intertek
SGS
Boston Analytical
EAG
Maxxam
ARL Bio Pharma
West Pharmaceutical
BioScreen
Microbac
RD Laboratories
Analytical Lab Group
Piramal Pharma Solutions
Global BioPharma Service market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BioPharma Service market, Segment by Type:
Raw Material
In-Process and Product
Finished Pharmaceutical
Others
Global BioPharma Service market, by Application
Analytical Testing
Drug Development Service
Drug Packaging and Delivery
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of BioPharma Service companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of BioPharma Service
1.1 BioPharma Service Market Overview
1.1.1 BioPharma Service Product Scope
1.1.2 BioPharma Service Market Status and Outlook
1.2 Global BioPharma Service Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global BioPharma Service Market Size by Region (2018-2029)
1.4 Global BioPharma Service Historic Market Size by Region (2018-2023)
1.5 Global BioPharma Service Market Size Forecast by Region (2024-2029)
1.6 Key Regions, BioPharma Service Market Size (2018-2029)
1.6.1 North America BioPharma Service Market Size (2018-2029)
1.6.2 Europe BioPharma Service Market Size (2018-2029)
1.6.3 Asia-Pacific BioPharma Service Market Size (2018-2029)
1.6.4 Latin America BioPharma Service Market Size (2018-2029)
1.6.5 Middle East & Africa BioPharma Service Market Size (2018-2029)
2 BioPharma Service Market by Type
2.1 Introduction
2.1.1 Raw Material
2.1.2 In-Process and Product
2.1.3 Finished Pharmaceutical
2.1.4 Others
2.2 Global BioPharma Service Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global BioPharma Service Historic Market Size by Type (2018-2023)
2.2.2 Global BioPharma Service Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America BioPharma Service Revenue Breakdown by Type (2018-2029)
2.3.2 Europe BioPharma Service Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific BioPharma Service Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America BioPharma Service Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa BioPharma Service Revenue Breakdown by Type (2018-2029)
3 BioPharma Service Market Overview by Application
3.1 Introduction
3.1.1 Analytical Testing
3.1.2 Drug Development Service
3.1.3 Drug Packaging and Delivery
3.1.4 Others
3.2 Global BioPharma Service Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global BioPharma Service Historic Market Size by Application (2018-2023)
3.2.2 Global BioPharma Service Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America BioPharma Service Revenue Breakdown by Application (2018-2029)
3.3.2 Europe BioPharma Service Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific BioPharma Service Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America BioPharma Service Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa BioPharma Service Revenue Breakdown by Application (2018-2029)
4 BioPharma Service Competition Analysis by Players
4.1 Global BioPharma Service Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in BioPharma Service as of 2022)
4.3 Date of Key Players Enter into BioPharma Service Market
4.4 Global Top Players BioPharma Service Headquarters and Area Served
4.5 Key Players BioPharma Service Product Solution and Service
4.6 Competitive Status
4.6.1 BioPharma Service Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eurofins
5.1.1 Eurofins Profile
5.1.2 Eurofins Main Business
5.1.3 Eurofins BioPharma Service Products, Services and Solutions
5.1.4 Eurofins BioPharma Service Revenue (US$ Million) & (2018-2023)
5.1.5 Eurofins Recent Developments
5.2 Pace Analytical Services
5.2.1 Pace Analytical Services Profile
5.2.2 Pace Analytical Services Main Business
5.2.3 Pace Analytical Services BioPharma Service Products, Services and Solutions
5.2.4 Pace Analytical Services BioPharma Service Revenue (US$ Million) & (2018-2023)
5.2.5 Pace Analytical Services Recent Developments
5.3 Catalent
5.3.1 Catalent Profile
5.3.2 Catalent Main Business
5.3.3 Catalent BioPharma Service Products, Services and Solutions
5.3.4 Catalent BioPharma Service Revenue (US$ Million) & (2018-2023)
5.3.5 Envigo Recent Developments
5.4 Envigo
5.4.1 Envigo Profile
5.4.2 Envigo Main Business
5.4.3 Envigo BioPharma Service Products, Services and Solutions
5.4.4 Envigo BioPharma Service Revenue (US$ Million) & (2018-2023)
5.4.5 Envigo Recent Developments
5.5 PPD
5.5.1 PPD Profile
5.5.2 PPD Main Business
5.5.3 PPD BioPharma Service Products, Services and Solutions
5.5.4 PPD BioPharma Service Revenue (US$ Million) & (2018-2023)
5.5.5 PPD Recent Developments
5.6 Element
5.6.1 Element Profile
5.6.2 Element Main Business
5.6.3 Element BioPharma Service Products, Services and Solutions
5.6.4 Element BioPharma Service Revenue (US$ Million) & (2018-2023)
5.6.5 Element Recent Developments
5.7 ALS
5.7.1 ALS Profile
5.7.2 ALS Main Business
5.7.3 ALS BioPharma Service Products, Services and Solutions
5.7.4 ALS BioPharma Service Revenue (US$ Million) & (2018-2023)
5.7.5 ALS Recent Developments
5.8 Intertek
5.8.1 Intertek Profile
5.8.2 Intertek Main Business
5.8.3 Intertek BioPharma Service Products, Services and Solutions
5.8.4 Intertek BioPharma Service Revenue (US$ Million) & (2018-2023)
5.8.5 Intertek Recent Developments
5.9 SGS
5.9.1 SGS Profile
5.9.2 SGS Main Business
5.9.3 SGS BioPharma Service Products, Services and Solutions
5.9.4 SGS BioPharma Service Revenue (US$ Million) & (2018-2023)
5.9.5 SGS Recent Developments
5.10 Boston Analytical
5.10.1 Boston Analytical Profile
5.10.2 Boston Analytical Main Business
5.10.3 Boston Analytical BioPharma Service Products, Services and Solutions
5.10.4 Boston Analytical BioPharma Service Revenue (US$ Million) & (2018-2023)
5.10.5 Boston Analytical Recent Developments
5.11 EAG
5.11.1 EAG Profile
5.11.2 EAG Main Business
5.11.3 EAG BioPharma Service Products, Services and Solutions
5.11.4 EAG BioPharma Service Revenue (US$ Million) & (2018-2023)
5.11.5 EAG Recent Developments
5.12 Maxxam
5.12.1 Maxxam Profile
5.12.2 Maxxam Main Business
5.12.3 Maxxam BioPharma Service Products, Services and Solutions
5.12.4 Maxxam BioPharma Service Revenue (US$ Million) & (2018-2023)
5.12.5 Maxxam Recent Developments
5.13 ARL Bio Pharma
5.13.1 ARL Bio Pharma Profile
5.13.2 ARL Bio Pharma Main Business
5.13.3 ARL Bio Pharma BioPharma Service Products, Services and Solutions
5.13.4 ARL Bio Pharma BioPharma Service Revenue (US$ Million) & (2018-2023)
5.13.5 ARL Bio Pharma Recent Developments
5.14 West Pharmaceutical
5.14.1 West Pharmaceutical Profile
5.14.2 West Pharmaceutical Main Business
5.14.3 West Pharmaceutical BioPharma Service Products, Services and Solutions
5.14.4 West Pharmaceutical BioPharma Service Revenue (US$ Million) & (2018-2023)
5.14.5 West Pharmaceutical Recent Developments
5.15 BioScreen
5.15.1 BioScreen Profile
5.15.2 BioScreen Main Business
5.15.3 BioScreen BioPharma Service Products, Services and Solutions
5.15.4 BioScreen BioPharma Service Revenue (US$ Million) & (2018-2023)
5.15.5 BioScreen Recent Developments
5.16 Microbac
5.16.1 Microbac Profile
5.16.2 Microbac Main Business
5.16.3 Microbac BioPharma Service Products, Services and Solutions
5.16.4 Microbac BioPharma Service Revenue (US$ Million) & (2018-2023)
5.16.5 Microbac Recent Developments
5.17 RD Laboratories
5.17.1 RD Laboratories Profile
5.17.2 RD Laboratories Main Business
5.17.3 RD Laboratories BioPharma Service Products, Services and Solutions
5.17.4 RD Laboratories BioPharma Service Revenue (US$ Million) & (2018-2023)
5.17.5 RD Laboratories Recent Developments
5.18 Analytical Lab Group
5.18.1 Analytical Lab Group Profile
5.18.2 Analytical Lab Group Main Business
5.18.3 Analytical Lab Group BioPharma Service Products, Services and Solutions
5.18.4 Analytical Lab Group BioPharma Service Revenue (US$ Million) & (2018-2023)
5.18.5 Analytical Lab Group Recent Developments
5.19 Piramal Pharma Solutions
5.19.1 Piramal Pharma Solutions Profile
5.19.2 Piramal Pharma Solutions Main Business
5.19.3 Piramal Pharma Solutions BioPharma Service Products, Services and Solutions
5.19.4 Piramal Pharma Solutions BioPharma Service Revenue (US$ Million) & (2018-2023)
5.19.5 Piramal Pharma Solutions Recent Developments
6 North America
6.1 North America BioPharma Service Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe BioPharma Service Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific BioPharma Service Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America BioPharma Service Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa BioPharma Service Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 BioPharma Service Market Dynamics
11.1 BioPharma Service Industry Trends
11.2 BioPharma Service Market Drivers
11.3 BioPharma Service Market Challenges
11.4 BioPharma Service Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
